Trade BHC stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Bausch Health Companies Inc (BHC) is trading at US$5.92, up 1.02% today as of Sep 14, 16:00 EDT. The company has a market capitalisation of US$2.41B. Over the past 52 weeks, BHC has traded between US$4.33 and US$8.00. On Syfe you can trade BHC with $0 commission and add it to your watchlist.
| Previous close | US$5.86 |
|---|---|
| Market cap | US$2.41B |
| P/E ratio | 1.34 |
| 52-week range | US$4.33 – US$8.00 |
| Volume | 5.18M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Bausch Health Companies Inc
Bausch Health Cos., Inc. engages in the development, manufacture and market of a range of branded, generic and branded generic pharmaceuticals, medical devices and over-the-counter products. It operates through the following segments: Salix, International, Solta Medical, Diversified Products, and Bausch + Lomb. The Salix segment consists of sales in the U.S. of GI products. Sales of the Xifaxan product line. The International segment comprises of sales, except for sales of Bausch + Lomb products and Solta aesthetic medical devices, outside the U.S and Puerto Rico of branded pharmaceutical products, branded generic pharmaceutical and OTC products. The Solta Medical segment refers to global sales of Solta Medical aesthetic medical devices. The Diversified Products segment covers sales in the U.S. of pharmaceutical products in the areas of neurology and certain other therapeutic classes, generic products, ortho dermatologic, and dentistry products. The Bausch + Lomb segment are global sales of Bausch + Lomb vision care, surgical and ophthalmic pharmaceuticals products. The company was founded on March 29, 1994, and is headquartered in Laval, Canada.
Year: 1994
Sector Update: Healthcare Stocks Decline Late Afternoon
Jul 30, 7:46 PM · MT Newswires
Bausch Health Companies Inc (BHC) stock is trading at US$5.92, +1.02% from the previous close of US$5.86.
The market cap for Bausch Health Companies Inc (BHC) stock is approximately US$2.41B.
The price-to-earnings ratio for Bausch Health Companies Inc (BHC) is 1.34, based on the latest reported earnings.
The 52-week high for Bausch Health Companies Inc (BHC) stock is US$8.00.
The 52-week low for Bausch Health Companies Inc (BHC) stock is US$4.33.
Bausch Health Companies Inc (BHC) does not currently pay a dividend.
Stay on top of BHC
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
